News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,992 Results
Type
Article (1948)
Company Profile (2)
Press Release (72042)
Section
Business (21686)
Career Advice (10)
Deals (4599)
Drug Delivery (1)
Drug Development (8311)
FDA (1821)
Job Trends (822)
News (37441)
Policy (3584)
Tag
2027 BioCapital Standard (1)
Academia (98)
Accelerated approval (5)
ADA (2)
Allergies (21)
Alliances (8215)
ALS (15)
Alzheimer's disease (178)
Antibody-drug conjugate (ADC) (109)
Approvals (1975)
Artificial intelligence (33)
ASCO (37)
Autoimmune disease (33)
Automation (2)
Bankruptcy (10)
Best Places to Work (606)
BIO (9)
Biosimilars (88)
Biotechnology (5)
Bladder cancer (30)
Brain cancer (7)
Breast cancer (63)
Cancer (653)
Cardiovascular disease (27)
Career advice (10)
CAR-T (16)
CDC (1)
Cell therapy (60)
Cervical cancer (5)
Clinical research (7802)
Collaboration (330)
Compensation (26)
Complete response letters (6)
COVID-19 (205)
CRISPR (1)
C-suite (96)
Cystic fibrosis (8)
Data (836)
Depression (16)
Dermatology (11)
Diabetes (41)
Diagnostics (645)
Digital health (7)
Drug discovery (41)
Drug pricing (1)
Duchenne muscular dystrophy (43)
Earnings (8244)
Events (7722)
Executive appointments (76)
FDA (2316)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (151)
Gene editing (7)
Generative AI (1)
Gene therapy (39)
GLP-1 (82)
Government (241)
Grass and pollen (1)
Guidances (39)
Healthcare (1103)
Hematology (14)
HIV (6)
Huntington's disease (3)
IgA nephropathy (23)
Immunology and inflammation (7)
Immuno-oncology (12)
Indications (27)
Infectious disease (231)
Inflammatory bowel disease (25)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (40)
Interviews (1)
IPO (1649)
Job creations (246)
Job search strategy (10)
JPM (3)
Kidney cancer (1)
Layoffs (6)
Legal (955)
Liver cancer (19)
Longevity (3)
Lung cancer (115)
Lymphoma (59)
Machine learning (1)
Manufacturing (127)
Marketing (1)
MASH (19)
Medical device (1176)
Medtech (1193)
Mergers & acquisitions (3143)
Metabolic disorders (108)
mRNA (7)
Multiple sclerosis (24)
NASH (1)
Neurodegenerative disease (35)
Neuropsychiatric disorders (7)
Neuroscience (333)
NextGen: Class of 2026 (231)
Non-profit (66)
Obesity (36)
Opinion (1)
Ovarian cancer (35)
Pain (19)
Pancreatic cancer (29)
Parkinson's disease (49)
Partnered (4)
Patents (73)
Patient recruitment (73)
Peanut (1)
People (5237)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (2123)
Phase 2 (3314)
Phase 3 (2927)
Pipeline (1171)
Policy (1)
Postmarket research (245)
Preclinical (722)
Press Release (2)
Prostate cancer (26)
Radiopharmaceuticals (26)
Rare diseases (84)
Real estate (617)
Regulatory (3047)
Reports (6)
Research institute (101)
Resumes & cover letters (1)
Rett syndrome (1)
RNA editing (3)
RSV (3)
Schizophrenia (23)
Series A (33)
Series B (23)
Service/supplier (1)
Sickle cell disease (8)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (434)
Stomach cancer (2)
Supply chain (13)
Vaccines (46)
Venture capital (7)
Weight loss (17)
Women's health (7)
Date
Today (6)
Last 7 days (44)
Last 30 days (198)
Last 365 days (2797)
2026 (1514)
2025 (2707)
2024 (3276)
2023 (3849)
2022 (7055)
2021 (6444)
2020 (5943)
2019 (3918)
2018 (3040)
2017 (3601)
2016 (3208)
2015 (4094)
2014 (3055)
2013 (2614)
2012 (2793)
2011 (2924)
2010 (2681)
Location
Africa (102)
Alabama (4)
Arizona (13)
Arkansas (1)
Asia (22274)
Australia (2489)
California (795)
Canada (466)
China (497)
Colorado (5)
Connecticut (23)
Delaware (7)
Europe (13532)
Florida (85)
Georgia (16)
Illinois (45)
India (51)
Indiana (28)
Japan (331)
Kansas (5)
Louisiana (2)
Maine (4)
Maryland (125)
Massachusetts (626)
Michigan (9)
Minnesota (37)
Missouri (3)
Nebraska (3)
Nevada (11)
New Hampshire (1)
New Jersey (475)
New York (279)
North Carolina (119)
Northern California (337)
Ohio (6)
Oregon (2)
Pennsylvania (147)
Puerto Rico (1)
Rhode Island (1)
South America (110)
South Carolina (1)
Southern California (390)
Tennessee (2)
Texas (59)
United States (3027)
Utah (29)
Vermont (1)
Virginia (59)
Washington D.C. (3)
Washington State (60)
Wisconsin (7)
73,992 Results for "gedeon richter ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Gedeon Richter Highlights Expanding Biosimilars Portfolio and Scientific Engagement at EULAR 2026
June 4, 2026
·
2 min read
Business
Gedeon Richter Selects Trial Interactive for Clinical Trial Management
TransPerfect Life Sciences, a leading global provider of solutions for product development and launch for the biopharmaceutical industry, announced that Gedeon Richter selected Trial Interactive’s award-winning eTMF platform and TI Collaborate eClinical solution for its upcoming clinical trials.
March 25, 2024
·
3 min read
Press Releases
Modular Devices Appoints Steve Richter as CEO to Drive Next Phase of Growth
April 7, 2026
·
3 min read
Genetown
Gedeon Richter and Sumitomo Pharma Receive Positive CHMP Opinion for RYEQO® for Treatment of Endometriosis
Gedeon Richter Plc. (‘Richter’) together with Sumitomo Pharma America, Inc. (‘SMPA’) and Sumitomo Pharma Switzerland GmbH (‘SMPS’) today announce that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (“EMA”) has adopted a positive opinion recommending the approval of a Type II Variation application for RYEQO®.
September 15, 2023
·
4 min read
News
AbbVie and Gedeon Richter Announce New Collaboration for the Discovery and Development of Novel Targets for Neuropsychiatric Conditions
October 24, 2024
·
10 min read
Press Releases
Faron Pharmaceuticals Ltd: Grant of Options - July 1, 2026
July 1, 2026
·
5 min read
Press Releases
Faron Pharmaceuticals Ltd: Registration of Treasury Shares
June 11, 2026
·
2 min read
Business
AbbVie and Gedeon Richter Announce Collaboration in Neuropsychiatric Diseases
AbbVie and Gedeon Richter Plc. announced a new co-development and license agreement to research, develop and commercialize novel dopamine receptor modulators for the potential treatment of neuropsychiatric diseases.
March 11, 2022
·
11 min read
Press Releases
Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT)
December 9, 2025
·
11 min read
Press Releases
Faron Pharmaceuticals Ltd: Directorate Appointment
May 5, 2026
·
3 min read
1 of 7,400
Next
